BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Bevacizumab
1
Vascular endothelial growth factor pathway’s influence on bevacizumab efficacy in metastatic colorectal cancer treatment
10/25/2024 10:27:31 AM | Browse: 67 | Download: 351
2
Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1
8/8/2024 4:58:16 AM | Browse: 127 | Download: 472
3
Synaptophysin-like 2 expression correlates with lymph node metastasis and poor prognosis in colorectal cancer patients
11/15/2022 10:19:35 AM | Browse: 501 | Download: 1800
4
Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review
7/14/2022 8:05:03 AM | Browse: 552 | Download: 1678
5
Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report
6/24/2022 9:00:24 AM | Browse: 445 | Download: 1314
6
Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
9/22/2021 8:09:41 AM | Browse: 583 | Download: 877
7
Colorectal cancer metastatic to the breast: A case report
9/10/2020 5:57:28 AM | Browse: 841 | Download: 1569
8
Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report
7/20/2020 2:28:50 AM | Browse: 849 | Download: 1997
9
Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports
4/28/2020 8:04:31 AM | Browse: 910 | Download: 1575
10
Primary tumor location and survival in colorectal cancer: A retrospective cohort study
4/15/2020 12:00:00 PM | Browse: 845 | Download: 1737
11
Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy
2/22/2019 4:33:37 AM | Browse: 1067 | Download: 1287
12
Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review
1/16/2019 8:39:45 AM | Browse: 904 | Download: 1826
13
Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors
12/14/2018 10:51:23 AM | Browse: 929 | Download: 1268
14
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
11/13/2018 8:04:45 AM | Browse: 1144 | Download: 1762
15
Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
12/20/2016 1:38:00 PM | Browse: 1256 | Download: 2125
16
Role of targeted therapy in metastatic colorectal cancer
9/12/2016 10:43:00 AM | Browse: 1168 | Download: 1986
17
Treatment of diabetic retinopathy: Recent advances and unresolved challenges
8/23/2016 8:55:00 AM | Browse: 1193 | Download: 1996
18
Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer
7/15/2016 3:38:00 PM | Browse: 1327 | Download: 2100
19
Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment
9/30/2015 4:28:00 PM | Browse: 1383 | Download: 1914
20
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
6/20/2015 5:38:00 PM | Browse: 1577 | Download: 3039
21
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab
5/13/2015 10:38:00 AM | Browse: 1198 | Download: 2517
22
Value of bevacizumab in treatment of colorectal cancer: A meta-analysis
4/27/2015 4:29:00 PM | Browse: 1272 | Download: 1904
23
Targeted therapy in first line treatment of RAS wild type colorectal cancer
3/16/2015 6:04:00 PM | Browse: 1199 | Download: 1640
24
FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma
2/11/2015 4:38:00 PM | Browse: 1131 | Download: 1279
25
Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status
11/19/2014 2:49:00 PM | Browse: 1196 | Download: 1481
26
Bevacizumab maintenance in metastatic colorectal cancer: How long?
11/10/2014 12:19:00 PM | Browse: 1162 | Download: 1641
27
Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy
10/20/2014 9:54:00 AM | Browse: 1230 | Download: 1856
28
Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases
9/16/2014 6:10:00 PM | Browse: 1276 | Download: 1191
29
Role of bevacizumab in colorectal cancer growth and its adverse effects: A review
9/15/2014 8:54:00 PM | Browse: 1319 | Download: 1307
30
Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives
9/11/2014 8:40:00 PM | Browse: 1147 | Download: 1654
31
Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012
9/3/2014 11:44:00 AM | Browse: 1233 | Download: 1641
32
Bevacizumab for the management of diabetic macular edema
9/1/2014 3:42:00 PM | Browse: 1265 | Download: 1175
33
Ranibizumab in diabetic macular edema
9/1/2014 2:50:00 PM | Browse: 1244 | Download: 1358
34
Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer
9/1/2014 10:30:00 AM | Browse: 1401 | Download: 1078
35
Targeting receptor tyrosine kinases in gastric cancer
8/28/2014 5:50:00 PM | Browse: 1229 | Download: 1423
36
Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review
8/26/2014 5:16:00 PM | Browse: 1292 | Download: 1062
37
Advances and new perspectives in the treatment of metastatic colon cancer
8/26/2014 4:37:00 PM | Browse: 1296 | Download: 1594
38
Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer
8/26/2014 4:36:00 PM | Browse: 1319 | Download: 1175
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345